Mark J. Axelrod

546 citations
15 papers · 387 indexed · h-index 8
Topics
Chronic Lymphocytic Leukemia Research (6 papers)Chronic Myeloid Leukemia Treatments (3 papers)Melanoma and MAPK Pathways (3 papers)
Partner nations
United StatesEgypt

In The Last Decade

Mark J. Axelrod

15 papers receiving 384 citations

Peers

Mark J. Axelrod
Comparison fields: 5 of 69
  • Molecular Biology 127
  • Physiology 117
  • Genetics 116
  • Pathology and Forensic Medicine 80
  • Oncology 73
Replace Benjamin Y. Owusu with:
Benjamin Y. Owusu United States
Yachao Yao China
Karim Iskander United States
Chandrashekar R. Ambati United States
Andreas Hedblom United States
Yasuko Tamura United States
Azadali Moorji Saudi Arabia
Katharina von Löhneysen United States
M Roques France
Mark J. Axelrod relative to Benjamin Y. Owusu United States Benjamin Y. Owusu's profile →
Citations per field
00.5×3.9×
Benjamin Y. Owusu · 1×
Citations per year

Countries citing papers authored by Mark J. Axelrod

Since Specialization
Citations

This map shows the geographic impact of Mark J. Axelrod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Axelrod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Axelrod more than expected).

Fields of papers citing papers by Mark J. Axelrod

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Axelrod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Axelrod. The network helps show where Mark J. Axelrod may publish in the future.

Co-authorship network of co-authors of Mark J. Axelrod

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Axelrod. A scholar is included among the top collaborators of Mark J. Axelrod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Axelrod. Mark J. Axelrod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 5
2 81
3 7
4 6
5 11
6 1
7 7
8 24
9 6
10 5
11 35
12 5
13 29
14 1
15 164

About Mark J. Axelrod

Mark J. Axelrod is a scholar working on Genetics, Hematology and Cancer Research, having authored 15 papers that have together received 387 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Melanoma and MAPK Pathways (3 papers). The work is most often cited by research in Genetics (116 citations), Endocrine and Autonomic Systems (44 citations) and Physiology (117 citations). Mark J. Axelrod has collaborated with scholars based in United States and Egypt. Frequent co-authors include Michael J. Weber, Vicki L. Gordon, Allan Doctor, Brian J. Capaldo, Anne C. Eischeid, T. McMahon, Thomas S. Maxey, Andrew J. Gow, Jaclyn Kline and Matthew J. Gurka. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026